The primitive protozoan pathogen of humans, Leishmania donovani, resides and multiplies in highly restricted micro-environments within their hosts (i.e. as promastigotes in the gut lumen of their sandfly vectors and as amastigotes in the phagolysosomal compartments of infected mammalian macrophages). Like other trypanosomatid parasites, they are purine auxotrophs (i.e. lack the ability to synthesize purines de novo) and therefore are totally dependent upon salvaging these essential nutrients from their hosts. In that context, in this study we identified a unique 35-kDa, dithiothreitol-sensitive nuclease and showed that it was constitutively released/secreted by both promastigote and amastigote developmental forms of this parasite. By using several different molecular approaches, we identified and characterized the structure of LdNuc s , a gene that encodes this new 35-kDa class I nuclease family member in these organisms. Homologous episomal expression of an epitope-tagged LdNuc s chimeric construct was used in conjunction with an anti-LdNuc s peptide antibody to delineate the functional and biochemical properties of this unique 35-kDa parasite released/ secreted enzyme. Results of coupled immunoprecipitation-enzyme activity analyses demonstrated that this "secretory" enzyme could hydrolyze a variety of synthetic polynucleotides as well as several natural nucleic acid substrates, including RNA and single-and double-stranded DNA. Based on these cumulative observations, we hypothesize that within the micro-environments of its host, this leishmanial "secretory" nuclease could function at a distance away from the parasite to harness (i.e. hydrolyze/access) host-derived nucleic acids to satisfy the essential purine requirements of these organisms. Thus, this enzyme might play an important role(s) in facilitating the survival, growth, and development of this important human pathogen.Leishmania are a group of primitive pathogenic trypanosomatid protozoan parasites that cause over 2 million new cases of human cutaneous, mucocutaneous, and fatal visceral disease (i.e. leishmaniasis) per year worldwide (1). All Leishmania parasites undergo a digenetic life cycle, which includes differentiation, development, and transmission between both a sand fly vector and a mammalian host. Within their hosts, these parasites reside and multiply in highly restricted micro-environments (i.e. as extracellular, flagellated promastigote forms in the alimentary tract of their sandfly vectors and as obligate intracellular amastigote forms in the phagolysosomal compartments of infected mammalian macrophages) (2). It is important to point out that Leishmania, like other trypanosomatid parasites, are incapable of the de novo biosynthesis of purines (3, 4). Thus, it seems obvious that in order to survive, these purine auxotrophs must be capable of salvaging these essential nutrients from their host environments. One such purported purine salvage mechanism involves a unique cell surface membraneanchored, bi-functional 3Ј-nucleotidase/nuclease that...